![Mark Engel](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark Engel
Fundador en
Excel PharmaStudies, Inc.
.
Perfil
Mark Engel is the founder of Excel PharmaStudies, Inc. Mr. Engel is currently the Chairman & Chief Executive Officer of Phagelux, Inc., the Chairman & Chief Executive Officer of Precisio Biotix Therapeutics, Inc., and the Chairman of Phagelux (Canada), Inc.
Cargos activos de Mark Engel
| Empresas | Cargo | Inicio |
|---|---|---|
Excel PharmaStudies, Inc.
 Excel PharmaStudies, Inc. Miscellaneous Commercial ServicesCommercial Services Provides regulatory, clinical research and quality assurance services | Fundador | - |
Phagelux, Inc.
 Phagelux, Inc. BiotechnologyHealth Technology Manufactures anti bacteriophages, lytic enzymes and new drug delivery systems | Director Ejecutivo | - |
Phagelux (Canada), Inc.
 Phagelux (Canada), Inc. BiotechnologyHealth Technology Developing anti bacterial phage based solutions | Presidente | 11/03/2015 |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
5
Relaciones de 1er grado
3
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 3 |
|---|---|
Excel PharmaStudies, Inc.
Excel PharmaStudies, Inc. Miscellaneous Commercial ServicesCommercial Services Provides regulatory, clinical research and quality assurance services | Commercial Services |
Phagelux, Inc.
Phagelux, Inc. BiotechnologyHealth Technology Manufactures anti bacteriophages, lytic enzymes and new drug delivery systems | Health Technology |
Phagelux (Canada), Inc.
Phagelux (Canada), Inc. BiotechnologyHealth Technology Developing anti bacterial phage based solutions | Health Technology |
- Bolsa de valores
- Insiders
- Mark Engel
